Description
STEMCELL Technologies will manufacture a proprietary medium developed for mammalian cell culture and protein expression used in the vaccine manufacturing process.
Amendment chain · 1 entry
Each notch is one published row for this agreement: #0 is the original (placed at its start date) and each later notch is an amendment (placed at its amendment date). The height is the agreement's total value as of that row — the source column is cumulative, not a change amount — so the line reads as the commitment over time and the right-most notch is the current commitment shown in the header.
- #02026-02-18$2,829,286
| Row | Date | Total value as of row | Change vs previous | Description on this row |
|---|---|---|---|---|
| #0 original | 2026-02-18(start date) | $2,829,286 | — | STEMCELL Technologies will manufacture a proprietary medium developed for mammalian cell culture and protein e… |
Related records · 10
Records are related by an explicit link in the data, stated for each group below — never by text similarity. Values are each agreement's current commitment (latest amendment).
Other current agreements for the same recipient (business number 135714426)
| Ref | Department · program | Current value | FY |
|---|---|---|---|
| 033-2024-2025-Q4-819532 | Innovation, Science and Economic Development Canada | Innovation, Sciences et Développement économique Canada · SIF Stream2- Growth | $49,900,000 | FY2025 |
| 172-2020-2021-Q2-952647 | National Research Council Canada | Conseil national de recherches Canada · Industrial Research Assistance Program – Contributions to Firms | $500,000 | FY2021 |
| GC-WD-DEO-2019-2020-Q2-24 | Western Economic Diversification Canada | Diversification de l'économie de l'Ouest Canada · Regional Economic Growth through Innovation | $5,000,000 | FY2020 |
| 033-2017-2018-Q4-810905 | Innovation, Science and Economic Development Canada | Innovation, Sciences et Développement économique Canada · SIF Stream3- Attraction | $22,500,000 | FY2018 |
| GC-WD-DEO-2020-2021-Q1-787 | Western Economic Diversification Canada | Diversification de l'économie de l'Ouest Canada · Western Diversification Program | $946,560 | FY2015 |
Other recipients funded under "Life Sciences Fund Contributions" by Innovation, Science and Economic Development Canada | Innovation, Sciences et Développement économique Canada (most recent first)
| Ref | Recipient | Fiscal year | Current value | FY |
|---|---|---|---|---|
| 033-2025-2026-Q4-515742 | Applied Pharmaceutical Innovation | FY2026 | $21,928,275 | FY2026 |
| 033-2025-2026-Q4-515732 | Avivo Biomedical Inc | FY2026 | $10,994,000 | FY2026 |
| 033-2025-2026-Q4-515743 | Northern RNA Inc. | FY2026 | $6,037,700 | FY2026 |
| 033-2025-2026-Q4-515746 | Avivo Biomedical Inc | FY2026 | $10,994,000 | FY2026 |
| 033-2025-2026-Q4-515741 | Qidni Labs Inc. | FY2026 | $12,500,000 | FY2026 |
Cite as: Glassbox record view · Federal grants & contributions · 033-2025-2026-Q4-515888 · retrieved 2026-11-12.